FeesSafety
Pluang+

NEAR team identifies hacker, demands return of stolen funds after $3.8M exploit.

Market News
02 Oct 2026, 17:10 WIB
Tokenpost
View Source
Neutral
NEAR team identifies hacker, demands return of stolen funds after $3.8M exploit.

The NEAR Intents team identified the individual responsible for a recent exploit that resulted in losses on October 1. The hacker had moved about $3.8 million in stolen funds and subsequently sent small amounts of cryptocurrency to a recovery address, requesting contact via Signal. The team has given the hacker 48 hours to return the stolen funds, signaling ongoing efforts to recover the assets and resolve the situation.

The NEAR Intents exploit and recovery efforts provide context for cryptocurrency market activity. For readers following crypto markets, here is Pluang's snapshot as of Oct 02, 2026 20:45 WIB: 40 of 50 major cryptocurrencies rose today. Notable movers include SAND with a 60.88% increase and SXP with a 46.27% decrease in price.

More News

Dapirolizumab pegol shows higher response rates and sustained remission in SLE patients versus placebo in Phase 3 trial.

Dapirolizumab pegol shows higher response rates and sustained remission in SLE patients versus placebo in Phase 3 trial.

Dapirolizumab pegol (DZP), an investigational biologic for systemic lupus erythematosus (SLE), demonstrated greater treatment response rates compared to placebo when combined with standard care in the Phase 3 PHOENYCS GO trial. Using a novel Treatmen...

Market News
Bullish
5 hours ago
Valneva reports positive Phase 2 results for its tetravalent Shigella vaccine candidate showing safety and efficacy.

Valneva reports positive Phase 2 results for its tetravalent Shigella vaccine candidate showing safety and efficacy.

Valneva announced positive Phase 2 trial results for its tetravalent Shigella vaccine candidate S4V2, showing a favorable safety profile and encouraging immune responses in infants and adults. The infant trial in Kenya demonstrated significant antibo...

Company Fundamentals
Bullish
5 hours ago
argenx to acquire Unnatural Products for up to $1.15B to boost drug discovery with macrocyclic peptides

argenx to acquire Unnatural Products for up to $1.15B to boost drug discovery with macrocyclic peptides

argenx will acquire Unnatural Products (UNP) for $550 million upfront plus up to $600 million in milestones, totaling about $1.15 billion. UNP specializes in orally-delivered macrocyclic peptides targeting previously undruggable diseases, enhancing a...

Company Fundamentals
Bullish
5 hours ago
argenx to acquire Unnatural Products for up to $1.15B, expanding peptide drug discovery in immunology

argenx to acquire Unnatural Products for up to $1.15B, expanding peptide drug discovery in immunology

argenx announced it will acquire Unnatural Products, Inc. (UNP) for up to $1.15 billion, including upfront and milestone payments. This acquisition adds UNP's macrocyclic peptide discovery platform to argenx's antibody engineering capabilities, broad...

Company Fundamentals
Bullish
5 hours ago
ClearPoint Neuro posts strong Q3 with rising drug delivery revenue and promising future trials.

ClearPoint Neuro posts strong Q3 with rising drug delivery revenue and promising future trials.

ClearPoint Neuro reported solid third-quarter results, driven by increased revenue from its drug delivery services and steady sales in neurosurgery navigation equipment. The company sees encouraging signs for future growth in disposables linked to ca...

Company Fundamentals
Bullish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App